BETTER THERAPEUTICS, INC.

Analyst Reco. Better Therapeutics, Inc.

Equities

BTTX

US08773T1043

Market Closed - OTC Markets Other stock markets 02:59:08 2024-05-17 pm EDT			5-day change	1st Jan Change
0.0112 ^USD	-10.87%		+2.75%	-94.26%

Mar. 21	Better Therapeutics, Inc. Receives Notice of Default from Hercules Capital, Inc	CI
Mar. 20	Better Therapeutics, Inc.(NasdaqCM:BTTX) dropped from S&P TMI Index	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lake Street Adjusts Better Therapeutics' Price Target to $5 From $6, Keeps Buy Rating	23-04-14	MT
Chardan Lowers Price Target on Better Therapeutics to $9 From $14, Reflecting Higher Projected Sharecount Dilution, Maintains Buy Rating	23-03-31	MT
Chardan Cuts Price Target on Better Therapeutics to $14 From $17 on Higher Expected Share Count Dilution, Reiterates Buy Rating	22-11-15	MT
Chardan Adjusts Better Therapeutics' Price Target to $17 From $15, Keeps Buy Rating	22-07-29	MT
Chardan Raises Price Target on Better Therapeutics to $18 From $17, Maintains Buy Rating	22-03-16	MT
LifeSci Capital Starts Better Therapeutics at Outperform With $15 Price Target	21-12-28	MT
Chardan Starts Better Therapeutics at Buy With $17 Price Target	21-11-24	MT
Cowen Initiates Coverage on Better Therapeutics With Outperform Rating	21-11-10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW